Adults with differentiated thyroid cancer have a high 10-year disease-specific survival, even with radioactive iodine not ...

While hyperthyroidism affects about 1% of all Americans, women are 5 to 10 times more likely to have the condition than men, ...

11:28, Fri, Jan 16, 2026 Updated: 11:56, Fri, Jan 16, 2026 It might seem an unlikely prospect, but there must be some possibility, however remote, that a nuclear radiation emergency could strike the ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The launch this week of an oral pill version of Wegovy ...

A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving Americans access to an oral medication to treat obesity. The starting dose ...

Americans can now purchase a starter dose of Novo Nordisk’s weight loss drug Wegovy in pill form, the company announced Monday, pledging widespread availability. The 1.5 milligram starter dose of a ...

Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk announced Monday. Other strengths will be available as pills by the end of the ...

For years, pharmaceutical companies have been racing to develop a market-ready GLP-1 weight-loss pill to join the ranks of popular injectables. Today, Novo Nordisk’s oral version of Wegovy is ...

The FDA has approved a pill form of the popular GLP-1 weight-loss medication George Frey/Bloomberg via Getty The U.S. Food and Drug Administration has approved the pill form of Wegovy, the weight-loss ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. For years, GLP-1 medications like Novo ...

The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy, the first daily oral medication for obesity treatment. The once-daily tablet — ...

U.S. regulators approved the first GLP-1 weight-loss pill—a tablet formulation of Novo Nordisk’s NOVO.B1.17%increase; green up pointing triangle Ozempic and Wegovy—ushering in a new era of the obesity ...